![]()
|
|
||||||||
J. Biol. Chem., Vol. 261, Issue 28, 12960-12964, 10, 1986
RM Scarborough, DB Schenk, GA McEnroe, A Arfsten, LL Kang, K Schwartz and JA Lewicki
A series of truncated atrial natriuretic peptide analogs were examined as a
means of defining the structural requirements for receptor occupancy and
stimulation of cyclic GMP accumulation in bovine aortic smooth muscle
cells. It was determined that deletion of amino acids from the carboxyl
and/or amino termini of the peptides diminished their ability to increase
cyclic GMP levels. Deletion of amino acids from the carboxyl terminus had
the greatest effect, and atrial natriuretic peptide analogs lacking the
carboxyl-terminal phenylalanyl-arginyl- tyrosine tripeptide were
100-1000-fold less active than parent compounds in stimulating
intracellular cyclic GMP accumulation. In marked contrast to the cyclic GMP
effects, deletion of amino- and/or carboxyl-terminal amino acids had only
minor effects on the affinity of the peptides for specific smooth muscle
cell-associated receptors. Peptide analogs lacking the
phenylalanyl-arginyl-tyrosine tripeptide bound to receptors with an
affinity only 1.1-5-fold weaker than the parent compounds. Thus, there was
no correlation between apparent receptor binding affinity of atrial
natriuretic peptide analogs and potency of these same peptides for
stimulating intracellular cyclic GMP accumulation. Furthermore, analogs
that bound to receptors and failed to elicit significant cyclic GMP
responses did not antagonize or modulate increases in cyclic GMP induced by
parent compounds. These data are most consistent with the existence of
multiple subpopulations of atrial natriuretic peptide receptors on aortic
smooth muscle cells.
Truncated atrial natriuretic peptide analogs. Comparison between receptor binding and stimulation of cyclic GMP accumulation in cultured vascular smooth muscle cells
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
G. Boerrigter, L. C. Costello-Boerrigter, G. J. Harty, H. Lapp, and J. C. Burnett Jr. Des-serine-proline brain natriuretic peptide 3-32 in cardiorenal regulation Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2007; 292(2): R897 - R901. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. W. Zlock, L. Cao, J. Wu, and D. G. Gardner Thrombin Inhibits Atrial Natriuretic Peptide Receptor Activity in Cultured Bovine Endothelial Cells Hypertension, January 1, 1997; 29(1): 83 - 90. [Abstract] [Full Text] |
||||
![]() |
B. Li, J. Y. K. Tom, D. Oare, R. Yen, W. J. Fairbrother, J. A. Wells, and B. C. Cunningham Minimization of a Polypeptide Hormone Science, December 8, 1995; 270(5242): 1657 - 1660. [Abstract] [PDF] |
||||
![]() |
H. de Leon, M.-C. Bonhomme, G. Thibault, and R. Garcia Localization of Atrial Natriuretic Factor Receptors in the Mesenteric Arterial Bed : Comparison With Angiotensin II and Endothelin Receptors Circ. Res., July 1, 1995; 77(1): 64 - 72. [Abstract] [Full Text] |
||||
![]() |
T. Abe, Y. Arakawa, A. K. Rajasekaran, T.-H. Yu, and O. Wada Interaction of Atrial Natriuretic Peptide with Its Receptors in Bovine Lung Membranes J. Biol. Chem., March 31, 1995; 270(13): 7672 - 7678. [Abstract] [Full Text] [PDF] |
||||
![]() |
T Maack, M Suzuki, F. Almeida, D Nussenzveig, R. Scarborough, G. McEnroe, and J. Lewicki Physiological role of silent receptors of atrial natriuretic factor Science, October 30, 1987; 238(4827): 675 - 678. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |